Low-dose OKT3 is not effective in the treatment of steroid-resistant acute renal allograft rejections

Transplant Proc. 1998 Nov;30(7):3106-7. doi: 10.1016/s0041-1345(98)00951-8.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Dose-Response Relationship, Drug
  • Female
  • Graft Rejection / drug therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Neoplasms / drug therapy*
  • Lymphocyte Depletion
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use*
  • Prednisolone / therapeutic use
  • Steroids / therapeutic use
  • T-Lymphocytes / immunology
  • Treatment Failure

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3
  • Steroids
  • Cyclosporine
  • Prednisolone
  • Azathioprine